Related Experiment Video
Updated: Aug 13, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Cryptococcus flips its lid - membrane phospholipid asymmetry modulates antifungal drug resistance and virulence
Erika Shor1, Yina Wang1, David S Perlin2
1Public Health Research Institute Center, New Jersey Medical School, Rutgers University, Newark, New Jersey, USA.
Abstract:
Human fungal infections are increasing in prevalence and acquisition of antifungal drug resistance, while our antifungal drug armamentarium remains very limited, constituting a significant public health problem. Despite the fact that prominent antifungal drugs target the fungal cell membrane, very little is known about how fungal membrane biology regulates drug-target interactions. Asymmetrical phospholipid distribution is an essential property of biological membranes, which is maintained by a group of transporters that dynamically translocate specific phospholipid groups across the membrane bilayer. Lipid flippase is the enzyme responsible for translocation of certain phospholipids, including phosphatidylserine (PS), across the plasma membrane from the exocytoplasmic to the cytoplasmic leaflet. Loss of lipid flippase leads to abnormal phospholipid distribution and impaired intracellular vesicular trafficking. The recent research article by Huang et al. reported that in pathogenic fungus Cryptococcus neoformans loss of lipid flippase activity sensitized cryptococcal cells to multiple classes of antifungal drugs, including the cell wall active echinocandins, and abolished fungal virulence in murine models. This finding demonstrates that lipid flippase may promote fungal drug resistance and virulence and indicates that this enzyme may represent a novel antifungal drug target.
Insights
Infections from human fungi are rising, and drug resistance is growing. Researchers found that blocking lipid flippase, an enzyme in fungal cells, could make antifungal drugs more effective and reduce fungal infections.
Area of Science:
- Mycology
- Biochemistry
- Drug Discovery
Background:
- Rising prevalence of human fungal infections and increasing antifungal drug resistance pose a significant public health challenge.
- Antifungal drugs often target the fungal cell membrane, but the role of membrane biology in drug interactions is poorly understood.
- Phospholipid asymmetry is crucial for membrane function and is maintained by lipid transporters, including lipid flippases.
Purpose of the Study:
- To investigate the role of lipid flippase in antifungal drug resistance and virulence in the pathogenic fungus *Cryptococcus neoformans*.
- To explore lipid flippase as a potential novel target for antifungal drug development.
Main Methods:
- Studied the effects of lipid flippase activity loss on *Cryptococcus neoformans*.
- Assessed the sensitivity of *Cryptococcus neoformans* to various antifungal drugs.
- Evaluated the impact of lipid flippase on fungal virulence in murine models.
Main Results:
- Loss of lipid flippase activity resulted in abnormal phospholipid distribution and impaired vesicular trafficking in *Cryptococcus neoformans*.
- Reduced lipid flippase activity sensitized cryptococcal cells to multiple classes of antifungal drugs, including echinocandins.
- Abolished fungal virulence in murine models, indicating lipid flippase's role in pathogenesis.
Conclusions:
- Lipid flippase activity contributes to antifungal drug resistance and virulence in *Cryptococcus neoformans*.
- Inhibition of lipid flippase represents a promising strategy for developing new antifungal therapies.
- Targeting lipid flippase could overcome existing drug resistance mechanisms in fungal infections.
Related Concept Videos
Asymmetric Lipid Bilayer
Biosynthesis of Lipids
Development of Antibiotic Resistance
Cryptococcal Meningitis
Candidiasis
Antifungal Agents

